Fluoxetine-induced conditioned place preference: A preliminary study

Synapse

Volumn 25, Issue 3, 1997, Pages 309-311

  Collu, Maria ^a,c   Poggiu, Alessandra S ^a   Pani, Luca ^a   Serra, Gino ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c Dept of Neurosciences ^*  (Italy)

Author keywords

antidepressants; conditioned place preference; dopamine; fluoxetine; reward

Indexed keywords

ANTIDEPRESSANT AGENT; COCAINE; FLUOXETINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG EFFECT; INTRAGASTRIC DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DRUG EVALUATION, PRECLINICAL; FLUOXETINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN UPTAKE INHIBITORS;

EID: 0030900947     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199703)25:3<309::AID-SYN11>3.0.CO;2-R     Document Type: Article

References (19)

1. Arborelius, L., Chergui, K., Murase, S., Nomikos, G.G., Höök, B.B., Chouvet, G., Hacksell, U., and Svensson, T.H. (1993) The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg's Arch. Pharmacol., 347:353-362.
2. Ashby, C.R., Jr., Minabe, Y., Ramachandran, C., Strecker, R.E., and Dewey, S.L. (1995) The effect of acute and chronic administration of (±) FLX on spontaneously active midbrain dopamine neurons: An in vivo electrophysiological study. Soc. Neurosci. Abstr., Vol. 21, Part 1:153.2.
3. Bardo, M.T., Rowlett, J.K., and Harris, M.J. (1995) Conditioned place preference using opiate and stimulant drugs: A meta-analysis. Neurosci. Biobehav. Rev., 19:39-51.
4. Batki, S.L., Washburn, A., Manfredi, L., Murphy, J., Herbst, M.D., Delucchi, K., Jones, T., Nanda, N., Jacob III, P., and Jones, R.T. (1995) Fluoxetine in primary and secondary cocaine dependence: Outcome using quantitative benzoylecgonine concentration. In: NIDA Res. Monograph 153. Problems of Drug Dependence, Vol. II, p. 140.
5. Blier, P., and deMontigny, C. (1994) Current advances and trends in the treatment of depression. TIPS 15:220-226.
6. Carroll, M.E., Lac, S.T., Asencio, M., and Kragh, R. (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav., 35:237-244.
7. Collu, M., Pani, L., Gessa, G.L., and Serra, G. (1994) Chronic imipramine potentiates cocaine-induced CPP. Polish J. Pharmacol., 46:315-316.
8. Collu, M., Poggiu, A.S., and Serra, G. (1996) Antidepressants sensitize the dopamine mesolimbic system mediating reward. Behav. Pharmacol. 7 (Suppl. 1):18-19.
9. Fibiger, H.C. (1993) Mesolimbic dopamine: An analysis of its role in motivated behaviour. Semin. Neurosci., 5:321-327.
10. Fletcher, P.J., Tampakeras, M., and Yeomans, J.S. (1995) Median raphe injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation. Pharmacol. Biochem. Behav., 52:65-71.
11. Messiha, F.S. (1993) Fluoxetine: A spectrum of clinical applications and postulates of underlying mechanisms. Neurosci. Biobehav. Rev., 17:385-396.
12. Papp, M., and Willner, P. (1991) 8-OH-DPAT-induced place preference and place aversion: Effects of PCPA and dopamine antagonists. Psychopharmacology, 103:99-102.
13. Prisco, S., Pagannone, S., and Esposito, E. (1994) Serotonin-dopamine interaction in the rat ventral tegmental area: An electrophysiological study in vivo. J. Pharmacol. Exp. Ther., 271:83-90.
14. Richardson, N.R., and Roberts, D.C.S. (1991) Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration. Life Sci., 49:833-840.
15. Serra, G., Collu, M., D'Aquila, P.S., and Gessa, G.L. (1992) Role of the mesolimbic dopamine system in the mechanism of action of antidepressants. Pharmacol. Toxicol., 71 (Suppl. 1):72-85.
16. Simon, B.B., and Appel, J.B. (1995) Dopaminergic and serotonergic properties of FLX. Soc. Neurosci. Abstr., Vol. 21, Part 2:445.2.
17. Sternbach, H. (1991) The serotonin syndrome. Am. J. Psichiatry, 148:705-713.
18. Washburn, A.M., Batki, S.L., Delucchi, K., Murphy, J., Jones, T.A., and Nanda, N. (1995) Predictors of outcome in a clinical trial of FLX treatment of primary cocaine dependence. In: NIDA Res. Monograph 153. Problems of Drug dependence, Vol. II, p. 139.
19. Winters, T.A., and Slifer, B.L. (1989) Discriminative stimulus properties of cocaine. Is there mediation by serotonin? FASEB J. 3:295.